Table 2.
Outcome | Method | SNP (n) | β | 95% CI | P-value |
---|---|---|---|---|---|
TC | Weighted median | 49 | -0.025 | -0.036, -0.015 | 4.42 × 10-6 |
Inverse variance weighted | 49 | -0.028 | -0.039, -0.018 | 2.16 × 10-7 | |
MR Egger | 49 | -0.010 | -0.039, -0.019 | 0.494 | |
LDL | Weighted median | 49 | -0.015 | -0.025, -0.005 | 0.003 |
Inverse variance weighted | 49 | -0.018 | -0.027, -0.009 | 1.39 × 10-4 | |
MR Egger | 49 | -0.002 | -0.028, 0.023 | 0.848 | |
HDL | Weighted median | 49 | -0.013 | -0.021, -0.004 | 0.004 |
Inverse variance weighted | 49 | -0.012 | -0.019, -0.004 | 0.002 | |
MR Egger | 49 | -0.004 | -0.025, 0.016 | 0.683 |
beta (β), a ratio of changes in standard deviations; SLE, systemic lupus erythematosus; TC, total cholesterol; LDL, low-density lipoprotein; HDL, high-density lipoprotein; SNP, single-nucleotide polymorphism; CI, confidence interval.